AstraZeneca's $1.2B acquisition of Gracell Biotechnologies expands its cell therapy capabilities and presence in China's pharmaceutical market, strengthening its position and commitment to innovative treatments.
Trained lung cells reduce inflammation and prevent acute lung injury, according to a groundbreaking study. Discover the potential of this research for novel cell therapies.
Kincell Bio - Startup launching production hubs to simplify cell therapy manufacturing for biotech companies. Join us in advancing life-changing therapies!
Emerging startups are bridging the gap in #CellTherapy manufacturing, providing cost-effective and in-house production capabilities to young drugmakers struggling to scale up. Find out more in our article. #GeneTherapy #Biotech #Pharmaceuticals
Trained lung cells reduce inflammation and prevent acute lung injury, according to a groundbreaking study. Discover the potential of this research for novel cell therapies.
AstraZeneca's $1.2B acquisition of Gracell Biotechnologies expands its cell therapy capabilities and presence in China's pharmaceutical market, strengthening its position and commitment to innovative treatments.